In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study

被引:0
|
作者
F Bonifazi
G Bandini
M Stanzani
F Palandri
B Giannini
M Arpinati
G Rosti
M Baccarani
机构
[1] University of Bologna,Institute of Hematology ‘L. and A. Seràgnoli’
[2] S Orsola-Malpighi Hospital,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1025 / 1026
页数:1
相关论文
共 50 条
  • [41] Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation (ASCT) in previously untreated patients with peripheral T-cell lymphoma (PTCL). Results of a prospective phase II study from the GELCAB.
    Lopez-Guillermo, A
    Mercadal, S
    Briones, J
    Xicoy, B
    Pedro, C
    Escoda, L
    Estany, C
    Camos, M
    Ribera, JM
    Martino, R
    Montserrat, E
    BLOOD, 2005, 106 (11) : 587A - 588A
  • [42] Preliminary results of a Nordic phase II study on dose-intensive induction and high-dose therapy (HDT) with autologous stem cell rescue (ASCR) as primary treatment for peripheral T-cell lymphomas (PTCL).
    d'Amore, F
    Holte, H
    Cavallin-Ståhl, E
    Enblad, G
    Jantunen, E
    Ralfkiaer, E
    Anderson, H
    Lauritzsen, G
    Hansen, M
    Telhaug, R
    Delabie, J
    Sundström, C
    BLOOD, 2003, 102 (11) : 292B - 292B
  • [43] High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study
    Cottu, PH
    Extra, JM
    Espie, M
    Marolleau, J
    de Roquancourt, A
    Makke, J
    Miclea, JM
    Laurence, V
    Mayeur, D
    Lerebours, F
    Cuvier, C
    Marty, M
    BRITISH JOURNAL OF CANCER, 2001, 85 (09) : 1240 - 1246
  • [44] High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II study
    P H Cottu
    J M Extra
    M Espie
    J P Marolleau
    A de Roquancourt
    J Makke
    J M Miclea
    V Laurence
    D Mayeur
    F Lerebours
    C Cuvier
    M Marty
    British Journal of Cancer, 2001, 85 : 1240 - 1246
  • [45] PRELIMINARY RESULTS FROM AN OPEN-LABEL, PHASE II STUDY OF TIPIFARNIB IN RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA
    Witzig, T.
    Sokol, L.
    Jacobsen, E.
    Advani, R.
    Mondejar, R.
    Piris, M.
    Burrows, F.
    Melvin, C.
    Mishra, V.
    Scholz, C.
    Gualberto, A.
    HAEMATOLOGICA, 2017, 102 : 222 - 222
  • [46] A phase I/II study of Xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma
    Vij, R
    Vescio, RA
    Borrello, IM
    Martin, TG
    Siegel, D
    Berenson, JR
    Janmohamed, F
    Berenson, RJ
    Frohlich, MW
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 76 - 76
  • [47] Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
    Chiappella, Annalisa
    Dodero, Anna
    Evangelista, Andrea
    Re, Alessandro
    Orsucci, Lorella
    Usai, Sara Veronica
    Castellino, Claudia
    Stefoni, Vittorio
    Pinto, Antonio
    Zanni, Manuela
    Ciancia, Rosanna
    Ghiggi, Chiara
    Rossi, Francesca Gaia
    Arcari, Annalisa
    Ilariucci, Fiorella
    Zilioli, Vittorio Ruggero
    Flenghi, Leonardo
    Celli, Melania
    Volpetti, Stefano
    Benedetti, Fabio
    Ballerini, Filippo
    Musuraca, Gerardo
    Bruna, Riccardo
    Patti, Caterina
    Leonardi, Francesco
    Arcaini, Luca
    Magagnoli, Massimo
    Cavallo, Federica
    Bermema, Anisa
    Tucci, Alessandra
    Boccomini, Carola
    Ciccone, Giovannino
    Carniti, Cristiana
    Pileri, Stefano Aldo
    Corradini, Paolo
    LEUKEMIA, 2023, 37 (02) : 433 - 440
  • [48] A phase I/II study of Xcellerated T cells™ after autologous peripheral blood stem cell transplantation in patients with multiple myeloma
    Martin, T
    Vij, R
    Vescio, R
    Borrello, I
    Siegel, D
    Bashey, A
    DiPersio, J
    Berenson, J
    Ferrand, C
    Janmohamed, F
    Yuan, V
    Bouchard, L
    Hami, L
    Berenson, RJ
    Bonyhadi, M
    Frohlich, MW
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 27 - 28
  • [49] Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
    Annalisa Chiappella
    Anna Dodero
    Andrea Evangelista
    Alessandro Re
    Lorella Orsucci
    Sara Veronica Usai
    Claudia Castellino
    Vittorio Stefoni
    Antonio Pinto
    Manuela Zanni
    Rosanna Ciancia
    Chiara Ghiggi
    Francesca Gaia Rossi
    Annalisa Arcari
    Fiorella Ilariucci
    Vittorio Ruggero Zilioli
    Leonardo Flenghi
    Melania Celli
    Stefano Volpetti
    Fabio Benedetti
    Filippo Ballerini
    Gerardo Musuraca
    Riccardo Bruna
    Caterina Patti
    Francesco Leonardi
    Luca Arcaini
    Massimo Magagnoli
    Federica Cavallo
    Anisa Bermema
    Alessandra Tucci
    Carola Boccomini
    Giovannino Ciccone
    Cristiana Carniti
    Stefano Aldo Pileri
    Paolo Corradini
    Leukemia, 2023, 37 : 433 - 440
  • [50] Partial T-Cell Depletion By Low-Dose Anti-Thymocyte Globulin to Reduce Severe Acute and Chronic Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation
    Imataki, Osamu
    Ohbayashi, Yumiko
    Ohue, Yukiko
    Matsuka, Harumi
    Uemura, Makiko
    Kadowaki, Norimitsu
    BLOOD, 2015, 126 (23)